Sharifah N A, Lee B R, Clarence-Ko C H, Tan G C, Shiran M S, Naqiyah I, Rohaizak M, Fuad I, Tamil A M
Department of Pathology, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):663-70.
Breast cancer is the commonest cancer affecting females in Malaysia, contributing 31% of all newly diagnosed cases amongst Malaysian women. The present retrospective cohort study evaluated the relationship between cerbB- 2 onco-protein overexpression with various tumour characteristics and survival rate of breast cancer patients treated at the Universiti Kebangsaan Malaysia Medical Centre (UKMMC) between 1996-2000. CerbB- 2 oncoprotein overexpression was determined by immunohistochemistry (IHC) and tumors showing 2+ positivity were verified by Fluorescence In Situ Hybridization (FISH). One hundred and seventy two patients were eligible for the study with a short-term follow-up (median) of 5.1 years. C-erbB-2 oncoprotein overexpression correlated with lymph node positivity, oestrogen receptor (ER) and progesterone receptor (PR) negativity. Univariate analyses showed shorter disease free survival (DFS) and overall survival (OS) in patients with cerbB- 2 oncoprotein overexpression, Malay ethnicity, higher tumour grade, lymph node positivity, ER and PR negativity. In a subgroup of patients with c-erbB-2 oncoprotein overexpression, a shorter OS was observed in those with lymph node positivity, ER and PR negativity. In multivariate prognostic analysis, lymph node status, ER status and tumour grading were the strongest independent prognostic factors for both OS and DFS. However, c-erbB-2 status was not a significantly independent prognostic factor, even in subsets with lymph node positive or negative group. C-erbB-2 oncoprotein overexpression correlated well with lymph node status, ER and PR. Shorter OS and DFS were significantly observed in patients with c-erbB-2 oncoprotein overexpression. Lymph node status, ER status and tumour grading were the only three independent prognostic factors for OS and DFS in this study. Although c-erbB-2 expression is obviously important from a biological standpoint, multivariate analysis showed that it is not an independent prognostic indicator in breast carcinoma in the local population.
乳腺癌是马来西亚女性中最常见的癌症,占马来西亚女性新诊断病例的31%。本回顾性队列研究评估了1996年至2000年期间在马来西亚国民大学医学中心(UKMMC)接受治疗的乳腺癌患者中,cerbB-2癌蛋白过表达与各种肿瘤特征及生存率之间的关系。通过免疫组织化学(IHC)确定cerbB-2癌蛋白过表达,对显示2+阳性的肿瘤通过荧光原位杂交(FISH)进行验证。172名患者符合研究条件,短期随访(中位数)为5.1年。C-erbB-2癌蛋白过表达与淋巴结阳性、雌激素受体(ER)和孕激素受体(PR)阴性相关。单因素分析显示,cerbB-2癌蛋白过表达、马来族裔、肿瘤分级较高、淋巴结阳性、ER和PR阴性的患者无病生存期(DFS)和总生存期(OS)较短。在c-erbB-2癌蛋白过表达的患者亚组中,淋巴结阳性、ER和PR阴性的患者OS较短。在多因素预后分析中,淋巴结状态、ER状态和肿瘤分级是OS和DFS最强的独立预后因素。然而,c-erbB-2状态不是一个显著的独立预后因素,即使在淋巴结阳性或阴性亚组中也是如此。C-erbB-2癌蛋白过表达与淋巴结状态、ER和PR密切相关。c-erbB-2癌蛋白过表达的患者中观察到显著较短的OS和DFS。淋巴结状态、ER状态和肿瘤分级是本研究中OS和DFS仅有的三个独立预后因素。尽管从生物学角度来看,c-erbB-2表达显然很重要,但多因素分析表明,它不是当地人群乳腺癌的独立预后指标。